NCT06290167 A New 360° Dual-task Based Protocol for the Pre-clinical In-hospital and At-home Rehabilitation of Elderly: DUAL-Rehab
| NCT ID | NCT06290167 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Auxologico Italiano |
| Condition | Cognitive Decline |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2023-07-03 |
| Primary Completion | 2026-04-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2023-07-03 with a primary completion date of 2026-04-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this project is two-fold 1. to develop a Dual-Task training exploiting the potentiality of the 360° technology in terms of interactivity and ecological validity 2. to investigate its efficacy in improving the cognitive functioning in a randomized clinical trial for 2 different populations: subjects with subjective memory complaints and mild cognitive impairment. Specifically, participants will follow an integrated training including 2 phases: 1)in-hospital rehabilitation, where subjects will be provided sessions of the training in immersive modality; 2)at-home rehabilitation, where older adults will be asked to perform at home the non-immersive version of the training using a tablet. Expected outcome is an improvement in cognitive functioning (assessed with a complete neuropsychological battery) after the training, thus advancing literature about non-pharmacological interventions in the preclinical stages of dementia along with innovative technical instruments.
Eligibility Criteria
Inclusion Criteria (group of SMC): * \> 65 years old * self-reported memory complaints * score on Mini-Mental State Examination greater than or equal to 27/30 (normal range) Exclusion Criteria: * no evidence of objective impairments on the neuropsychological testing, scores on the Clinical Dementia Rating \< 0.5 Inclusion Criteria (group of MCI): * \> 65 years old * a self-reported (or reported by a caregiver) cognitive decline * an objective impairment on the neuropsychological testing * scores on the Clinical Dementia Rating \< 0.5. Exclusion Criteria: * no dementia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06290167 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Cognitive Decline. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06290167 currently recruiting?
Yes, NCT06290167 is actively recruiting participants. Contact the research team at e.pedroli@auxologico.it for enrollment information.
Where is the NCT06290167 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06290167 clinical trial?
NCT06290167 is sponsored by Istituto Auxologico Italiano. The trial plans to enroll 90 participants.